Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 678301, 7 pages
http://dx.doi.org/10.1155/2014/678301
Research Article

Emergent Bacteria in Cystic Fibrosis: In Vitro Biofilm Formation and Resilience under Variable Oxygen Conditions

1Institute for Biotechnology and Bioengineering (IBB), Centre for Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2LEPAE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal

Received 22 February 2014; Accepted 15 April 2014; Published 29 April 2014

Academic Editor: Andrei Surguchov

Copyright © 2014 Susana P. Lopes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Worlitzsch, R. Tarran, M. Ulrich et al., “Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients,” The Journal of Clinical Investigation, vol. 109, no. 3, pp. 317–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Tunney, E. R. Klem, A. A. Fodor et al., “Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis,” Thorax, vol. 66, no. 7, pp. 579–584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Tunney, T. R. Field, T. F. Moriarty et al., “Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 9, pp. 995–1001, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Worlitzsch, C. Rintelen, K. Böhm et al., “Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients,” Clinical Microbiology and Infection, vol. 15, no. 5, pp. 454–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Lyczak, C. L. Cannon, and G. B. Pier, “Lung infections associated with cystic fibrosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 194–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Chen, Q. Xia, and L. Ju, “Competition between oxygen and nitrate respirations in continuous culture of Pseudomonas aeruginosa performing aerobic denitrification,” Biotechnology and Bioengineering, vol. 93, no. 6, pp. 1069–1078, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Alvarez-Ortega and C. S. Harwood, “Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration,” Molecular Microbiology, vol. 65, no. 1, pp. 153–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Hassett, T. R. Korfhagen, R. T. Irvin et al., “Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies,” Expert Opinion on Therapeutic Targets, vol. 14, no. 2, pp. 117–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Lopes, N. F. Azevedo, and M. O. Pereira, “Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy,” Critical Reviews in Microbiology, 2014. View at Publisher · View at Google Scholar
  10. F. Bittar, H. Richet, J. Dubus et al., “Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients,” PLoS ONE, vol. 3, no. 8, Article ID e2908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Coenye, J. Goris, T. Spilker, P. Vandamme, and J. J. LiPuma, “Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov,” Journal of Clinical Microbiology, vol. 40, no. 6, pp. 2062–2069, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Chiron, H. Marchandai, F. Counil et al., “Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis,” Journal of Clinical Microbiology, vol. 43, no. 8, pp. 3938–3943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Aguirre, D. Morrison, B. D. Cookson, F. W. Gay, and M. D. Collins, “Phenotypic and phylogenetic characterization of some Gemella-like organisms from human infections: description of Dolosigranulum pigrum gen. nov., sp. nov,” Journal of Applied Bacteriology, vol. 75, no. 6, pp. 608–612, 1993. View at Google Scholar · View at Scopus
  14. L. LaClaire and R. Facklam, “Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 7, pp. 2001–2003, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Lécuyer, J. Audibert, A. Bobigny et al., “Dolosigranulum pigrum causing nosocomial pneumonia and septicemia,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3474–3475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Hoedemaekers, T. Schülin, B. Tonk, W. J. G. Melchers, and P. D. J. Sturm, “Ventilator-associated pneumonia caused by Dolosigranulum pigrum,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3461–3462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. P. Lopes, H. Ceri, N. F. Azevedo, and M. O. Pereira, “Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection,” International Journal of Antimicrobial Agents, vol. 40, pp. 260–263, 2012. View at Google Scholar
  18. M. G. Stevens and S. C. Olsen, “Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity,” Journal of Immunological Methods, vol. 157, no. 1-2, pp. 225–231, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ceri, M. E. Olson, C. Stremick, R. R. Read, D. Morck, and A. Buret, “The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms,” Journal of Clinical Microbiology, vol. 37, no. 6, pp. 1771–1776, 1999. View at Google Scholar · View at Scopus
  20. A. Lourenco, A. Ferreira, N. Veiga, I. Machado, M. O. Pereira, and N. F. Azevedo, “Biofomics: a web platform for the systematic and standardized collection of high-throughput biofilm data,” PLoS ONE, vol. 7, no. 6, Article ID e39960, 2012. View at Google Scholar
  21. M. Schobert and D. Jahn, “Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung,” International Journal of Medical Microbiology, vol. 300, no. 8, pp. 549–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Schertzer, S. A. Brown, and M. Whiteley, “Oxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsH,” Molecular Microbiology, vol. 77, no. 6, pp. 1527–1538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Hogardt and J. Heesemann, “Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung,” International Journal of Medical Microbiology, vol. 300, no. 8, pp. 557–562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. B. R. Boles and P. K. Singh, “Endogenous oxidative stress produces diversity and adaptability in biofilm communities,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, pp. 12503–12508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Mowat, S. Paterson, J. L. Fothergill et al., “Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 12, pp. 1674–1679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. I. A. Balfour-Lynn and J. S. Elborn, “Respiratory disease: infection,” in Cystic Fibrosis, M. Hodson, A. Bush, and D. M. Geddes, Eds., pp. 137–158, Hodder Arnold, London, UK, 2007. View at Google Scholar
  27. G. B. Rogers, L. R. Hoffman, M. Whiteley, T. W. V. Daniels, M. P. Carroll, and K. D. Bruce, “Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy,” Trends in Microbiology, vol. 18, no. 8, pp. 357–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Ciofu and T. Tolker-Nielsen, “Antibiotc tolerance and resistance in biofilms,” in Biofilm Infections, T. Bjarnsholt, C. Moser, P. O. Jensen, and N. Hoiby, Eds., pp. 215–229, Springer, Berlin, Germany, 2011. View at Google Scholar
  29. O. Ciofu, L. F. Mandsberg, H. Wang, and N. Hoiby, “Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections,” FEMS Immunology and Medical Microbiology, vol. 65, no. 2, pp. 215–225, 2012. View at Google Scholar
  30. G. Doring and N. Hoiby, “Early intervention and prevention of lung disease in cystic fibrosis: a European consensus,” Journal of Cystic Fibrosis, vol. 3, no. 2, pp. 67–91, 2004. View at Google Scholar
  31. D. Hill, B. Rose, A. Pajkos et al., “Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions,” Journal of Clinical Microbiology, vol. 43, no. 10, pp. 5085–5090, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Høiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu, “Antibiotic resistance of bacterial biofilms,” International Journal of Antimicrobial Agents, vol. 35, no. 4, pp. 322–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Taccetti, E. Bianchini, L. Cariani et al., “Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols,” Thorax, vol. 67, no. 10, pp. 853–859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. Hassett, M. D. Sutton, M. J. Schurr, A. B. Herr, C. C. Caldwell, and J. O. Matu, “Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways,” Trends in Microbiology, vol. 17, no. 3, pp. 130–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. D. Sibley, K. Duan, C. Fischer et al., “Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections,” PLoS Pathogens, vol. 4, no. 10, Article ID e1000184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. B. Rogers, F. A. Stressmann, A. W. Walker, M. P. Carroll, and K. D. Bruce, “Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity,” Expert Review of Molecular Diagnostics, vol. 10, no. 2, pp. 187–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Wahab, I. A. Janahi, M. M. Marafia, and S. El-Shafie, “Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation,” Journal of Tropical Pediatrics, vol. 50, no. 4, pp. 229–233, 2004. View at Publisher · View at Google Scholar · View at Scopus